Profile

About Khaled

Khaled M. Musallam is group chief research officer at Burjeel Holdings in Abu Dhabi, where he founded the Center for Research on Rare Blood Disorders and directs the Thalassemia & Sickle Cell Center at Burjeel Medical City. He holds an MD from the American University of Beirut and a PhD from Leiden University, and is an adjunct professor at Khalifa University and Weill Cornell Medicine. His research draws on large observational datasets to study morbidity and mortality in thalassaemia, especially non-transfusion-dependent forms, iron overload and ineffective erythropoiesis, and has informed trials of new disease-modifying therapies. He received the European Hematology Association Clinical Excellence Award in 2025.
Published research

Publications

1 article

Research network

Co-authors

6 collaborators